Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE

被引:9
|
作者
Nakamuta, Makoto [1 ]
Kotoh, Kazuhiro [1 ]
Enjoji, Munechika [1 ]
Nawata, Hajime [1 ]
机构
[1] Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
Hepatocyte; Fibril-collagen; Fixed collagen;
D O I
10.3748/wjg.v11.i15.2264
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are central to the spontaneous resolution of liver fibrosis. The mechanisms involved have been investigated in hepatic stellate cells (HSC), but not in hepatocytes. We investigated the effects of fibril-and fixed-collagen on MMP-1 and TIMP-1 production in hepatocytes, using the HLE cell line. METHODS: Fibril type I and IV collagen were prepared by HCl digestion of type I and IV collagen, respectively. For fixed-collagen, culture dishes were coated with fibril type I or IV collagen and fixed by ultraviolet. Type I collagenase activity was measured using fluorescein isothiocyanate-labeled type I collagen. MMP-1 and TIMP-1 in HLE cells were measured by a one-step sandwich enzyme immunoassay. RESULTS: Both fibril type I and IV collagen significantly increased type I collagenase activity about two-fold compared with no fibril collagen. The effects of the fibril collagen were not affected by the coating condition. There was no significant difference in the effects on collagenase activity between cells cultured in medium containing fibril type I collagen and those cultured in the presence of type IV collagen. Both types of fibril collagen significantly increased MMP-1 production, and showed more than 10-fold higher levels of MMP-1 than the control. The enhanced MMP-1 production by fibril collagens was unaffected by the coating condition. By contrast, TIMP-1 production was not changed by the addition of fibril type I or IV collagen, and neither was it affected by the coating conditions. Coating with type I collagen significantly suppressed MMP-1 production by almost one-tenth compared with no coating. By contrast, TIMP-1 production was not affected by either the absence of a collagen coat or by increasing the concentration of the coating collagen. CONCLUSION: These results indicated that, in HLE cells, fibril-and fixed-collagen have opposite effects on MMP-1 production without affecting TIMP production. Fibril collagen induced collagenase activity by up-regulation of MMP-1 production without affecting TIMP-1 production. By contrast, fixed collagen reduced MMP-1 production. Our results suggest that hepatocytes might also play an important role in the regulation of the hepatic fibrosis alongside HSC. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:2264 / 2268
页数:5
相关论文
共 50 条
  • [31] Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1 tissue inhibitor in plasma of patients with prostate cancer
    Jung, K
    Nowak, L
    Lein, M
    Priem, F
    Schnorr, D
    Loening, SA
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (02) : 220 - 223
  • [32] Matrix metalloproteinase-1 in human gliomas
    Sykes, V
    Abd-Elfattah, N
    McCready, J
    Broaddus, WC
    Fillmore, HL
    NEURO-ONCOLOGY, 2004, 6 (04) : 313 - 313
  • [33] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [34] Effect of estrogen on the expression of matrix metalloproteinase-1,-3, and tissue inhibitor of metalloproteinase-1 in osteoarthritis chondrocyte.
    Lee, YJ
    Kwon, YE
    Lee, JJ
    Lee, EB
    Song, YW
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S61 - S61
  • [35] Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A
    Song, XZ
    Xia, JP
    Bi, ZG
    CHINESE MEDICAL JOURNAL, 2004, 117 (12) : 1838 - 1841
  • [36] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618
  • [37] Influence of hypoxia on the expression of matrix metalloproteinase-1,-3 and tissue inhibitor of metalloproteinase-1 in rheumatoid synovial fibroblasts
    Cha, HS
    Ahn, KS
    Jeon, CH
    Kim, J
    Song, YW
    Koh, EM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (05) : 593 - 598
  • [38] Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1
    Iyer, Shalini
    Wei, Shuo
    Brew, Keith
    Acharya, K. Ravi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) : 364 - 371
  • [39] Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
    Henry, MT
    McMahon, K
    Mackarel, AJ
    Prikk, K
    Sorsa, T
    Maisi, P
    Sepper, R
    FitzGerald, MX
    O'Connor, CM
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) : 1220 - 1227
  • [40] Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A
    宋秀祖
    夏济平
    毕志刚
    Chinese Medical Journal, 2004, (12)